淋巴浆细胞淋巴瘤
医学
华登氏巨球蛋白血症
淋巴瘤
巨球蛋白血症
肿瘤科
内科学
多发性骨髓瘤
作者
Shaji Kumar,Natalie S. Callander,Kehinde Adekola,Larry D. Anderson,Muhamed Baljević,Rachid Baz,Erica Campagnaro,Jorge J. Castillo,Caitlin Costello,Christopher R. D’Angelo,Benjamin A. Derman,Srinivas Devarakonda,Noura Elsedawy,Alfred L. Garfall,Kelly Godby,Jens Hillengaß,Leona Holmberg,Myo Htut,Carol Ann Huff,Malin Hultcrantz
标识
DOI:10.6004/jnccn.2024.0001
摘要
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.
科研通智能强力驱动
Strongly Powered by AbleSci AI